| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189898 | Bulletin du Cancer | 2016 | 15 Pages |
Abstract
These data provide strong evidence to support the potential of associating combinatorial targeted and/or immunotherapeutic regimens in patients with GBM that may change patient outcome.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Antoine Schernberg, Aurélien Marabelle, Christophe Massard, Jean-Pierre Armand, Sarah Dumont, Eric Deutsch, Frédéric Dhermain,